US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CG Oncology Inc.

74.67

-1.1900-1.57%

Volume:304.80K

Turnover:22.96M

Market Cap:6.62B

PE:-27.42

High:79.23

Open:76.84

Low:73.89

Close:75.86

52wk High:80.97

52wk Low:26.25

Shares:88.64M

Float Shares:64.73M

Volume Ratio:0.89

T/O Rate:0.47%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.7235

EPS(LYR):-2.0826

ROE:-26.41%

ROA:-17.67%

PB:6.43

PE(LYR):-35.85

Loading ...

Overview Company News Filings

CG Oncology Reports 'Encouraging' Data From Study of Intravesical Combination Therapy to Treat Bladder Cancer

MT Newswires Live

CG Oncology reports Phase 2 CORE-008 combo trial posts 92.3% complete response rate

CG Oncology Inc - No Grade 3 or Higher Treatment-Related Adverse Events or Deaths Reported

THOMSON REUTERS

CG Oncology Inc - High-Grade Event-Free Survival 96.0% at 3 Months, 89.5% at 6 Months in ITT Population

THOMSON REUTERS

CG Oncology Inc - Efficacy Comparable Across Treatment Arms and Bcg-Exposed or Bcg-Unresponsive Populations

THOMSON REUTERS

CG Oncology Reports Positive First Results From Core‑008 Cohort Cx Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk Bcg-Exposed and Bcg-Unresponsive Patients

THOMSON REUTERS

CG Oncology Price Target Raised to $82.00/Share From $77.00 by Truist Securities

CG Oncology, Inc. (CGON) Gets a Buy from Truist Financial

CG Oncology Inc : Truist Securities Raises Target Price to $82 From $77

THOMSON REUTERS

U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology

CG Oncology to present Phase 2 trial results for cretostimogene-gemcitabine combo in NMIBC

CG Oncology’s Presence at American Urological Association (AUA) Annual Meeting Underscores its Strong Commitment to NMIBC

CG Oncology price target raised to $80 from $77 at Wedbush

CG Oncology Analysts Boost Their Forecasts Following Q1 Earnings

Benzinga Earnings

CG Oncology's BLA Completion Target for Creto in Q4 to Comfort Investors, RBC Says

MT Newswires Live

CG Oncology Inc reports results for the quarter ended March 31 - Earnings Summary

CG Oncology Is Maintained at Outperform by Wedbush

CG Oncology, Inc. (CGON) Receives a Rating Update from a Top Analyst

RBC Capital Remains a Buy on CG Oncology, Inc. (CGON)

CG Oncology Earns Buy Rating as Analyst Sees High Phase III Success Odds and Strengthened BLA Timeline for Lead Asset Creto

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/CGON/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CGON","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CGON\",,,,,undefined,":{"symbol":"CGON","market":"US","secType":"STK","nameCN":"CG Oncology Inc.","latestPrice":74.67,"timestamp":1788368365270,"preClose":75.86,"halted":0,"volume":304797,"delay":0,"changeRate":-0.015686791457948823,"floatShares":64732200,"shares":88640375,"eps":-2.72351,"marketStatus":"Trading","change":-1.19,"latestTime":"09-02 12:59:25 EDT","open":76.84,"high":79.23,"low":73.89,"amount":22962288.594198,"amplitude":0.070393,"askPrice":74.8,"askSize":23,"bidPrice":74.65,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-2.72351,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788379200000},"marketStatusCode":2,"adr":0,"listingDate":1706158800000,"exchange":"NASDAQ","adjPreClose":75.86,"preHourTrading":{"tag":"盘前","latestPrice":76.88,"preClose":75.86,"latestTime":"09:29 EDT","volume":2988,"amount":226376.10900000003,"timestamp":1788355799984,"change":1.02,"changeRate":0.013446,"amplitude":0.07237},"postHourTrading":{"tag":"盘后","latestPrice":75.86,"preClose":75.86,"latestTime":"19:30 EDT","volume":10113,"amount":767170.8072,"timestamp":1788305405861,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.893903,"impliedVol":0.9539,"impliedVolPercentile":0.7302},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CGON\",,,,,undefined,":{"symbol":"CGON","floatShares":64732200,"roa":"-17.67%","roe":"-26.41%","lyrEps":-2.082636,"volumeRatio":0.893903,"shares":88640375,"dividePrice":0,"high":79.23,"amplitude":0.070393,"preClose":75.86,"low":73.89,"week52Low":26.245,"pbRate":"6.43","psRate":"1062.75","week52High":80.97,"institutionHeld":0,"latestPrice":74.67,"committee":-0.393939,"eps":-2.72351,"divideRate":0,"volume":304797,"delay":0,"ttmEps":-2.72351,"open":76.84,"prevYearClose":41.52,"prevWeekClose":74.34,"prevMonthClose":75.16,"prevQuarterClose":71.05,"fiveDayClose":78.42,"twentyDayClose":72.42,"sixtyDayClose":54.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CGON\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"CGON","fiscalQuarterEnding":"2026/06","expectedEps":-0.7,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":-0.9},{"market":"US","date":"2026-05-08","symbol":"CGON","fiscalQuarterEnding":"2026/03","expectedEps":-0.58,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778212800000,"reportTimeType":"pre","actualEps":-0.71},{"market":"US","date":"2026-02-27","symbol":"CGON","fiscalQuarterEnding":"2025/12","expectedEps":-0.61,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772168400000,"reportTimeType":"pre","actualEps":-0.51},{"market":"US","date":"2025-11-14","symbol":"CGON","fiscalQuarterEnding":"2025/09","expectedEps":-0.57,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-0.57},{"market":"US","date":"2025-08-08","symbol":"CGON","fiscalQuarterEnding":"2025/06","expectedEps":-0.49,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754625600000,"reportTimeType":"pre","actualEps":-0.54}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CGON\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CGON\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.7333,"hold":0.0667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7333,"analysts":15,"updateTime":1779249600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CGON\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CGON","date":"2026-08-31","current":-27.853762,"percent":0.543582,"low":-77.942097,"twenty":-41.844115,"median":-30.379621,"eighty":-21.807821,"high":-13.496527,"avg":-32.763215,"sd":12.84538,"marketCap":6589525477},"quantilePoints":[{"date":"2024-01-26","current":-62.124194,"twenty":-62.124194,"median":-62.124194,"eighty":-62.124194,"marketCap":2539823423},{"date":"2024-02-02","current":-61.712969,"twenty":-61.712969,"median":-60.379514,"eighty":-59.355029,"marketCap":2523011292},{"date":"2024-02-09","current":-63.452965,"twenty":-62.124194,"median":-60.590915,"eighty":-59.355029,"marketCap":2594147579},{"date":"2024-02-16","current":-77.177799,"twenty":-70.608092,"median":-61.918582,"eighty":-60.168112,"marketCap":3155259972},{"date":"2024-02-23","current":-75.080046,"twenty":-72.448911,"median":-64.672589,"eighty":-60.20714,"marketCap":3069497532},{"date":"2024-03-01","current":-72.705845,"twenty":-73.870179,"median":-70.608092,"eighty":-60.516111,"marketCap":2972433066},{"date":"2024-03-08","current":-64.818944,"twenty":-72.891228,"median":-69.827533,"eighty":-60.799064,"marketCap":2649992888},{"date":"2024-03-15","current":-60.493345,"twenty":-72.302556,"median":-67.469593,"eighty":-60.20714,"marketCap":2473149409},{"date":"2024-03-22","current":-66.867912,"twenty":-72.162706,"median":-65.355579,"eighty":-60.438055,"marketCap":2733760852},{"date":"2024-03-28","current":-56.207672,"twenty":-71.967566,"median":-64.762028,"eighty":-59.842879,"marketCap":2732086332},{"date":"2024-04-05","current":-51.752186,"twenty":-71.648838,"median":-63.50175,"eighty":-58.14191,"marketCap":2515518513},{"date":"2024-04-12","current":-54.631116,"twenty":-71.284577,"median":-62.382039,"eighty":-56.136384,"marketCap":2655454642},{"date":"2024-04-19","current":-48.420853,"twenty":-71.001624,"median":-61.712969,"eighty":-54.576279,"marketCap":2353592420},{"date":"2024-04-26","current":-49.627262,"twenty":-70.73168,"median":-60.54213,"eighty":-53.208102,"marketCap":2412232322},{"date":"2024-05-03","current":-54.151294,"twenty":-70.286112,"median":-60.183337,"eighty":-53.600185,"marketCap":2632131954},{"date":"2024-05-10","current":-35.176138,"twenty":-69.778748,"median":-59.371617,"eighty":-52.278619,"marketCap":2000537303},{"date":"2024-05-17","current":-36.289307,"twenty":-68.393255,"median":-58.232975,"eighty":-49.860318,"marketCap":2063845445},{"date":"2024-05-24","current":-35.140985,"twenty":-67.52163,"median":-57.330453,"eighty":-49.032283,"marketCap":1998538098},{"date":"2024-05-31","current":-40.179539,"twenty":-67.228921,"median":-56.207672,"eighty":-47.173317,"marketCap":2285090743},{"date":"2024-06-07","current":-40.894311,"twenty":-66.477632,"median":-55.878652,"eighty":-42.192617,"marketCap":2325741235},{"date":"2024-06-14","current":-40.788853,"twenty":-65.885708,"median":-55.522213,"eighty":-41.278647,"marketCap":2319743621},{"date":"2024-06-21","current":-37.625109,"twenty":-65.85969,"median":-54.631116,"eighty":-40.788853,"marketCap":2139815216},{"date":"2024-06-28","current":-35.445642,"twenty":-65.443392,"median":-54.494024,"eighty":-40.683395,"marketCap":2015864537},{"date":"2024-07-05","current":-36.125261,"twenty":-64.796178,"median":-54.151294,"eighty":-39.560851,"marketCap":2054515824},{"date":"2024-07-12","current":-40.378738,"twenty":-64.675841,"median":-53.136814,"eighty":-38.206301,"marketCap":2296419569},{"date":"2024-07-15","current":-41.491907,"twenty":-64.64657,"median":-52.780375,"eighty":-38.236766,"marketCap":2359727711},{"date":"2024-08-02","current":-39.652248,"twenty":-64.6173,"median":-52.752957,"eighty":-38.267232,"marketCap":2255102676},{"date":"2024-08-09","current":-38.949194,"twenty":-63.924553,"median":-51.752186,"eighty":-38.000071,"marketCap":2215118586},{"date":"2024-08-16","current":-40.572681,"twenty":-63.472479,"median":-49.956283,"eighty":-38.105529,"marketCap":2307449488},{"date":"2024-08-23","current":-42.377221,"twenty":-62.965116,"median":-49.723226,"eighty":-38.189896,"marketCap":2410077328},{"date":"2024-08-30","current":-43.2618,"twenty":-62.33047,"median":-48.934948,"eighty":-38.276606,"marketCap":2460385093},{"date":"2024-09-06","current":-44.299706,"twenty":-62.063778,"median":-48.270052,"eighty":-38.375033,"marketCap":2519412871},{"date":"2024-09-13","current":-41.079839,"twenty":-61.869081,"median":-45.980618,"eighty":-38.588613,"marketCap":2336292606},{"date":"2024-09-20","current":-46.127835,"twenty":-61.368222,"median":-44.806865,"eighty":-38.861791,"marketCap":2623382252},{"date":"2024-09-27","current":-43.379744,"twenty":-60.747027,"median":-44.736098,"eighty":-39.046612,"marketCap":2467092795},{"date":"2024-10-04","current":-42.412604,"twenty":-60.551887,"median":-44.517902,"eighty":-39.324835,"marketCap":2412089639},{"date":"2024-10-11","current":-40.667036,"twenty":-60.382766,"median":-44.458898,"eighty":-39.52313,"marketCap":2312815649},{"date":"2024-10-18","current":-43.356155,"twenty":-60.203473,"median":-44.063818,"eighty":-39.574912,"marketCap":2465751255},{"date":"2024-10-25","current":-42.990529,"twenty":-60.177247,"median":-43.698192,"eighty":-39.657154,"marketCap":2444957379},{"date":"2024-10-31","current":-42.837202,"twenty":-60.01213,"median":-43.662809,"eighty":-39.673778,"marketCap":2436237366},{"date":"2024-11-08","current":-46.068863,"twenty":-59.381569,"median":-43.651015,"eighty":-39.804577,"marketCap":2620028401},{"date":"2024-11-15","current":-32.980568,"twenty":-59.208121,"median":-43.63922,"eighty":-39.654701,"marketCap":2400853462},{"date":"2024-11-22","current":-30.044833,"twenty":-58.542987,"median":-43.538968,"eighty":-38.997903,"marketCap":2187143689},{"date":"2024-11-29","current":-32.283796,"twenty":-58.232975,"median":-43.444613,"eighty":-38.328163,"marketCap":2350131206},{"date":"2024-12-06","current":-31.17825,"twenty":-58.005312,"median":-43.379744,"eighty":-38.000071,"marketCap":2269651893},{"date":"2024-12-13","current":-26.821099,"twenty":-57.745125,"median":-43.279491,"eighty":-37.543086,"marketCap":1952468717},{"date":"2024-12-20","current":-26.031423,"twenty":-56.915781,"median":-43.120267,"eighty":-36.394765,"marketCap":1894983493},{"date":"2024-12-27","current":-27.044066,"twenty":-56.349294,"median":-43.061296,"eighty":-36.125261,"marketCap":1968699839},{"date":"2025-01-03","current":-26.914002,"twenty":-56.207672,"median":-43.037707,"eighty":-35.33784,"marketCap":1959231684},{"date":"2025-01-10","current":-28.298257,"twenty":-56.136384,"median":-42.978735,"eighty":-34.953504,"marketCap":2059999900},{"date":"2025-01-17","current":-27.034776,"twenty":-55.969133,"median":-42.872585,"eighty":-33.374909,"marketCap":1968023542},{"date":"2025-01-24","current":-32.158189,"twenty":-55.840266,"median":-42.689773,"eighty":-32.852839,"marketCap":2340987506},{"date":"2025-01-31","current":-31.530712,"twenty":-55.653821,"median":-42.565931,"eighty":-32.283796,"marketCap":2295309701},{"date":"2025-02-07","current":-31.405216,"twenty":-55.437216,"median":-42.394913,"eighty":-32.036945,"marketCap":2286174140},{"date":"2025-02-14","current":-29.805151,"twenty":-55.004006,"median":-42.206678,"eighty":-31.677123,"marketCap":2169695737},{"date":"2025-02-21","current":-29.512328,"twenty":-54.631116,"median":-41.999801,"eighty":-31.530712,"marketCap":2148379428},{"date":"2025-02-28","current":-25.768383,"twenty":-54.494024,"median":-41.775708,"eighty":-31.373843,"marketCap":1875835192},{"date":"2025-03-07","current":-28.226,"twenty":-54.39406,"median":-41.609082,"eighty":-31.094637,"marketCap":2054739928},{"date":"2025-03-14","current":-27.138374,"twenty":-54.151294,"median":-41.292708,"eighty":-30.560445,"marketCap":1975565066},{"date":"2025-03-21","current":-29.020804,"twenty":-53.671473,"median":-41.068045,"eighty":-30.21301,"marketCap":2112598481},{"date":"2025-03-28","current":-28.173711,"twenty":-53.493253,"median":-40.922206,"eighty":-29.826066,"marketCap":2050933444},{"date":"2025-04-04","current":-16.223536,"twenty":-52.780375,"median":-40.788853,"eighty":-29.478125,"marketCap":1428303862},{"date":"2025-04-11","current":-15.26259,"twenty":-52.725539,"median":-40.592885,"eighty":-29.073094,"marketCap":1343703153},{"date":"2025-04-17","current":-17.504797,"twenty":-52.648767,"median":-40.36956,"eighty":-28.807616,"marketCap":1541104808},{"date":"2025-04-25","current":-18.630229,"twenty":-51.927664,"median":-39.710836,"eighty":-28.715432,"marketCap":1640186719},{"date":"2025-05-02","current":-24.014988,"twenty":-51.631545,"median":-39.587801,"eighty":-28.276198,"marketCap":2114255557},{"date":"2025-05-09","current":-20.891121,"twenty":-50.318205,"median":-39.192738,"eighty":-28.046644,"marketCap":1839233409},{"date":"2025-05-16","current":-18.305859,"twenty":-49.931606,"median":-38.624431,"eighty":-27.822323,"marketCap":1932311557},{"date":"2025-05-23","current":-18.60193,"twenty":-49.805481,"median":-38.19927,"eighty":-27.481395,"marketCap":1963563934},{"date":"2025-05-30","current":-18.941329,"twenty":-49.745161,"median":-38.000071,"eighty":-27.137812,"marketCap":1999389828},{"date":"2025-06-06","current":-19.230179,"twenty":-49.665648,"median":-37.795014,"eighty":-26.986466,"marketCap":2029879952},{"date":"2025-06-13","current":-19.136302,"twenty":-49.503879,"median":-37.543086,"eighty":-26.644583,"marketCap":2019970662},{"date":"2025-06-20","current":-18.977435,"twenty":-49.032283,"median":-37.168124,"eighty":-26.449487,"marketCap":2003201094},{"date":"2025-06-27","current":-18.825789,"twenty":-48.437304,"median":-36.365471,"eighty":-26.243173,"marketCap":1987193779},{"date":"2025-07-03","current":-19.425152,"twenty":-48.360533,"median":-36.207284,"eighty":-25.994262,"marketCap":2050460785},{"date":"2025-07-11","current":-19.576798,"twenty":-47.916755,"median":-36.101826,"eighty":-24.54782,"marketCap":2066468099},{"date":"2025-07-18","current":-20.551667,"twenty":-47.047797,"median":-35.158562,"eighty":-23.322415,"marketCap":2169372265},{"date":"2025-07-25","current":-18.876337,"twenty":-46.758067,"median":-34.836328,"eighty":-20.953178,"marketCap":1992529551},{"date":"2025-08-01","current":-19.273506,"twenty":-46.459723,"median":-33.67043,"eighty":-19.630235,"marketCap":2034453470},{"date":"2025-08-08","current":-17.583734,"twenty":-46.116041,"median":-33.231407,"eighty":-19.436706,"marketCap":1856086249},{"date":"2025-08-15","current":-15.454183,"twenty":-46.05471,"median":-32.738157,"eighty":-19.425152,"marketCap":1979387202},{"date":"2025-08-22","current":-15.466089,"twenty":-45.994601,"median":-32.283796,"eighty":-19.321744,"marketCap":1980912154},{"date":"2025-08-29","current":-15.90364,"twenty":-45.910989,"median":-32.179105,"eighty":-19.234852,"marketCap":2036954126},{"date":"2025-09-05","current":-18.418814,"twenty":-45.632471,"median":-32.073773,"eighty":-19.17963,"marketCap":2359100156},{"date":"2025-09-12","current":-19.740397,"twenty":-45.219668,"median":-31.708497,"eighty":-19.194072,"marketCap":2528369785},{"date":"2025-09-19","current":-23.109837,"twenty":-44.877631,"median":-31.635292,"eighty":-19.201294,"marketCap":2959931094},{"date":"2025-09-26","current":-21.716818,"twenty":-44.736098,"median":-31.530712,"eighty":-19.230179,"marketCap":2781511754},{"date":"2025-10-03","current":-23.725981,"twenty":-44.665332,"median":-31.426132,"eighty":-19.253545,"marketCap":3038847340},{"date":"2025-10-10","current":-26.467372,"twenty":-44.523799,"median":-31.321553,"eighty":-19.273506,"marketCap":3389967451},{"date":"2025-10-17","current":-24.913619,"twenty":-44.512005,"median":-31.136443,"eighty":-19.29517,"marketCap":3190961264},{"date":"2025-10-24","current":-24.991009,"twenty":-44.50021,"median":-30.85309,"eighty":-19.316833,"marketCap":3200873450},{"date":"2025-10-31","current":-25.28271,"twenty":-44.458898,"median":-30.516316,"eighty":-19.341386,"marketCap":3238234765},{"date":"2025-11-07","current":-23.627755,"twenty":-44.299706,"median":-30.278194,"eighty":-19.345718,"marketCap":3026266489},{"date":"2025-11-14","current":-22.478812,"twenty":-44.252528,"median":-29.998382,"eighty":-19.366088,"marketCap":2879108658},{"date":"2025-11-21","current":-21.67833,"twenty":-43.981257,"median":-29.826066,"eighty":-19.425152,"marketCap":3283920147},{"date":"2025-11-28","current":-23.877581,"twenty":-43.896338,"median":-29.564618,"eighty":-19.425152,"marketCap":3617071466},{"date":"2025-12-05","current":-23.819005,"twenty":-43.743011,"median":-29.395876,"eighty":-19.425152,"marketCap":3608198186},{"date":"2025-12-12","current":-22.157586,"twenty":-43.700551,"median":-29.125384,"eighty":-19.430929,"marketCap":3356519708},{"date":"2025-12-19","current":-20.235238,"twenty":-43.669886,"median":-28.978972,"eighty":-19.432373,"marketCap":3065314802},{"date":"2025-12-26","current":-21.374801,"twenty":-43.648656,"median":-28.805205,"eighty":-19.445371,"marketCap":3237940425},{"date":"2026-01-02","current":-22.10966,"twenty":-43.629785,"median":-28.780272,"eighty":-19.471368,"marketCap":3349259752},{"date":"2026-01-09","current":-22.327988,"twenty":-43.592043,"median":-28.623402,"eighty":-19.508919,"marketCap":3382332885},{"date":"2026-01-16","current":-28.260107,"twenty":-43.542507,"median":-28.614819,"eighty":-19.546469,"marketCap":4280954119},{"date":"2026-01-23","current":-29.740475,"twenty":-43.516559,"median":-28.759356,"eighty":-19.598802,"marketCap":4505206097},{"date":"2026-01-30","current":-28.446485,"twenty":-43.476458,"median":-28.670137,"eighty":-19.697535,"marketCap":4309187282},{"date":"2026-02-06","current":-26.199308,"twenty":-43.389179,"median":-28.638782,"eighty":-19.761114,"marketCap":3968776006},{"date":"2026-02-13","current":-27.487973,"twenty":-43.379744,"median":-28.51571,"eighty":-19.844698,"marketCap":4163988159},{"date":"2026-02-20","current":-30.044003,"twenty":-43.379744,"median":-28.606237,"eighty":-19.847552,"marketCap":4551185819},{"date":"2026-02-27","current":-29.878927,"twenty":-43.356155,"median":-28.662149,"eighty":-19.899759,"marketCap":4526179303},{"date":"2026-03-06","current":-31.661561,"twenty":-43.297183,"median":-28.73844,"eighty":-19.924942,"marketCap":5097353024},{"date":"2026-03-13","current":-33.025153,"twenty":-43.2618,"median":-28.79073,"eighty":-20.020192,"marketCap":5316884544},{"date":"2026-03-20","current":-34.540838,"twenty":-43.202828,"median":-28.86184,"eighty":-20.05591,"marketCap":5560902272},{"date":"2026-03-27","current":-34.96565,"twenty":-43.120267,"median":-28.978972,"eighty":-20.155362,"marketCap":5629294784},{"date":"2026-04-02","current":-35.028585,"twenty":-43.082525,"median":-29.097931,"eighty":-20.219263,"marketCap":5639427008},{"date":"2026-04-10","current":-35.956876,"twenty":-43.063655,"median":-29.144068,"eighty":-20.488381,"marketCap":5788877312},{"date":"2026-04-17","current":-34.792578,"twenty":-43.05186,"median":-29.327361,"eighty":-20.553109,"marketCap":5601431168},{"date":"2026-04-24","current":-36.654406,"twenty":-43.040066,"median":-29.478125,"eighty":-20.588806,"marketCap":5901176128},{"date":"2026-05-01","current":-35.002362,"twenty":-42.999965,"median":-29.56202,"eighty":-20.746504,"marketCap":5635205248},{"date":"2026-05-08","current":-37.818134,"twenty":-42.981094,"median":-29.805151,"eighty":-20.869641,"marketCap":6088530416},{"date":"2026-05-15","current":-32.842427,"twenty":-42.940993,"median":-29.857726,"eighty":-21.111923,"marketCap":6133158960},{"date":"2026-05-22","current":-30.506829,"twenty":-42.912687,"median":-29.897542,"eighty":-21.194551,"marketCap":5696997731},{"date":"2026-05-29","current":-28.683693,"twenty":-42.865509,"median":-29.878927,"eighty":-21.209593,"marketCap":5356536185},{"date":"2026-06-05","current":-26.492151,"twenty":-42.752283,"median":-29.815608,"eighty":-21.22144,"marketCap":4947276710},{"date":"2026-06-12","current":-27.224239,"twenty":-42.688593,"median":-29.722786,"eighty":-21.263198,"marketCap":5083990543},{"date":"2026-06-18","current":-28.541998,"twenty":-42.650851,"median":-29.559423,"eighty":-21.301539,"marketCap":5330075443},{"date":"2026-06-26","current":-34.403428,"twenty":-42.587161,"median":-29.643702,"eighty":-21.330071,"marketCap":6424668133},{"date":"2026-07-02","current":-33.482414,"twenty":-42.563572,"median":-29.772813,"eighty":-21.349241,"marketCap":6252673310},{"date":"2026-07-10","current":-34.630139,"twenty":-42.52583,"median":-29.836524,"eighty":-21.374801,"marketCap":6467005320},{"date":"2026-07-17","current":-32.825896,"twenty":-42.405527,"median":-29.924736,"eighty":-21.377996,"marketCap":6130071873},{"date":"2026-07-24","current":-33.591046,"twenty":-42.372503,"median":-30.044833,"eighty":-21.412077,"marketCap":6272959879},{"date":"2026-07-31","current":-34.493168,"twenty":-42.353633,"median":-30.278194,"eighty":-21.497278,"marketCap":6441426603},{"date":"2026-08-07","current":-29.423755,"twenty":-42.206678,"median":-30.319483,"eighty":-21.67833,"marketCap":6601955104},{"date":"2026-08-14","current":-29.514529,"twenty":-42.183243,"median":-30.292724,"eighty":-21.716818,"marketCap":6622322416},{"date":"2026-08-21","current":-30.660187,"twenty":-41.999801,"median":-30.319483,"eighty":-21.782868,"marketCap":6879379503},{"date":"2026-08-28","current":-31.213264,"twenty":-41.846474,"median":-30.411711,"eighty":-21.800806,"marketCap":7003476028},{"date":"2026-08-31","current":-29.368359,"twenty":-41.844115,"median":-30.379621,"eighty":-21.807821,"marketCap":6589525477}],"updateTime":1788332407615},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CGON\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635308240","title":"CG Oncology Reports 'Encouraging' Data From Study of Intravesical Combination Therapy to Treat Bladder Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2635308240","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635308240?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:50","pubTimestamp":1778849429,"startTime":"0","endTime":"0","summary":"CG Oncology  reported Friday initial results from a phase 2 study evaluating intravesical cretostimogene grenadenorepvec in combination with gemcitabine sequential versus concurrent treatment schedules in patients with high-risk, non-muscle invasive bladder cancer.The biopharmaceutical company said the data \"demonstrate encouraging high-grade event-free survival, high complete response rates, and a well-tolerated safety profile.\"CG Oncology will present the data Saturday at the 2026 American Urological Association annual meeting in Washington, DC.\"As the first prospective intravesical-only combination study of its kind, these early data demonstrate robust clinical activity across both treatment schedules, a favorable safety profile, and comparable efficacy,\" Chief Medical Officer Vijay Kasturi said in a statement.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CG","BK4139","BK4135","CGON","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635081244","title":"CG Oncology reports Phase 2 CORE-008 combo trial posts 92.3% complete response rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635081244","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635081244?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:03","pubTimestamp":1778846624,"startTime":"0","endTime":"0","summary":"CG Oncology reported first Phase 2 results from CORE-008 Cohort CX, with data scheduled for presentation tomorrow at Society of Urologic Oncology session during 2026 American Urological Association annual meeting.Study tested intravesical cretostimogene grenadenorepvec combined with gemcitabine in high-risk non-muscle invasive bladder cancer patients previously exposed to BCG or classified as BCG-unresponsive.Results showed strong early signs of tumor clearance in patients with carcinoma in situ, with disease-control outcomes holding up over initial follow-up.Efficacy looked similar across concurrent versus sequential dosing schedules, supporting flexibility in how regimen could be used in practice.Safety profile appeared clean in this dataset, with no severe treatment-related events reported.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL5nLm7w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","SG9999014013.SGD","SG9999014021.USD","LU0314104364.USD","IE00BKPKM429.USD","LU2210150020.SGD","IE00BN0W2V16.EUR","SG9999014039.USD","SG9999014005.SGD","CGON","BK4139","IE00BGHQF748.EUR","BK4112","LU2095319765.USD","BK4585","IE00BN0W2W23.USD","IE00B64PRP62.GBP","NDAQ","BK4588","IE00B3QW5Z07.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635810600","title":"CG Oncology Inc - No Grade 3 or Higher Treatment-Related Adverse Events or Deaths Reported","url":"https://stock-news.laohu8.com/highlight/detail?id=2635810600","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635810600?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:00","pubTimestamp":1778846401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nTUA6TNV6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CGON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635810130","title":"CG Oncology Inc - High-Grade Event-Free Survival 96.0% at 3 Months, 89.5% at 6 Months in ITT Population","url":"https://stock-news.laohu8.com/highlight/detail?id=2635810130","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635810130?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:00","pubTimestamp":1778846401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nTUA6TNV6:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635084848","title":"CG Oncology Inc - Efficacy Comparable Across Treatment Arms and Bcg-Exposed or Bcg-Unresponsive Populations","url":"https://stock-news.laohu8.com/highlight/detail?id=2635084848","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635084848?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:00","pubTimestamp":1778846401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nTUA6TNV6:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CGON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635081906","title":"CG Oncology Reports Positive First Results From Core‑008 Cohort Cx Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk Bcg-Exposed and Bcg-Unresponsive Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2635081906","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635081906?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:00","pubTimestamp":1778846401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nTUA6TNV6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CGON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635746934","title":"CG Oncology Price Target Raised to $82.00/Share From $77.00 by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2635746934","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635746934?lang=en_us&edition=fundamental","pubTime":"2026-05-14 22:51","pubTimestamp":1778770260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CGON/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 14, 2026 10:51 ET (14:51 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","CG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635771450","title":"CG Oncology, Inc. (CGON) Gets a Buy from Truist Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2635771450","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635771450?lang=en_us&edition=fundamental","pubTime":"2026-05-14 19:37","pubTimestamp":1778758673,"startTime":"0","endTime":"0","summary":"In a report released today, Gregory Renza from Truist Financial reiterated a Buy rating on CG Oncology, Inc., with a price target of $82.00. Accord...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cg-oncology-inc-cgon-gets-a-buy-from-truist-financial-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cg-oncology-inc-cgon-gets-a-buy-from-truist-financial-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4135","IE00B3QW5Z07.USD","CGON","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4139","CG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635719348","title":"CG Oncology Inc : Truist Securities Raises Target Price to $82 From $77","url":"https://stock-news.laohu8.com/highlight/detail?id=2635719348","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635719348?lang=en_us&edition=fundamental","pubTime":"2026-05-14 19:00","pubTimestamp":1778756421,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nFWN41R0W5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CGON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635358799","title":"U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2635358799","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635358799?lang=en_us&edition=fundamental","pubTime":"2026-05-14 15:24","pubTimestamp":1778743446,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology May 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cisc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL4N41R0NP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DELL","DT","ATLC","CSCO","CIFR","CVNY","BXP","CMS","APGE","ET","CSCL","AKAM","ARMK","CGON","DOCS","ANTX","DTE","CIFG","CAKE","CIFU","CSR","ASTH","CPT","DLLL","MRVL","AVTX","MVLL","CVNA","CMP","CORZ","AN","CLH","AFRU","DMRA","DECK","AEE","CAVA","ARVN","AVB","AFRM","CVNX","ANDG","ABBV","ASO","CMC","EBAY","CSCS","CARR","MRVU","AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634230838","title":"CG Oncology to present Phase 2 trial results for cretostimogene-gemcitabine combo in NMIBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2634230838","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634230838?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:23","pubTimestamp":1778530992,"startTime":"0","endTime":"0","summary":"CG Oncology flagged first results from Phase 2 CORE-008 Cohort CX, testing intravesical cretostimogene grenadenorepvec combined with gemcitabine in high-risk non-muscle invasive bladder cancer patients previously exposed to BCG, including BCG-unresponsive disease.Results have not yet been disclosed, with presentations scheduled for May 15-16 at American Urological Association 2026 meeting in Washington.Readout is positioned as an early look at a combination approach in a difficult-to-treat setting, a key area for future clinical development and potential partnering or financing decisions.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL1B8n0R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","SG9999014013.SGD","SG9999014039.USD","LU2210149790.SGD","SG9999014005.SGD","BK4585","SG9999014021.USD","BK4139","IE00BN0W2T93.GBP","IE00BKPKM429.USD","BK4588","LU0314104364.USD","IE00BGHQF748.EUR","LU2210150020.SGD","CGON","IE00BN0W2W23.USD","LU2095319765.USD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","NDAQ","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634237772","title":"CG Oncology’s Presence at American Urological Association (AUA) Annual Meeting Underscores its Strong Commitment to NMIBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2634237772","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634237772?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:15","pubTimestamp":1778530500,"startTime":"0","endTime":"0","summary":"-First results from CORE-008 Cohort CX Phase 2 Trial evaluating intravesical combination therapy in High-Risk BCG-Exposed and BCG-Unresponsive patients to be presented- -Visit CG Oncology at booth #30","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/11/3292353/0/en/CG-Oncology-s-Presence-at-American-Urological-Association-AUA-Annual-Meeting-Underscores-its-Strong-Commitment-to-NMIBC.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BGHQF748.EUR","CG","CGON","BK4107","IE00B3QW5Z07.USD","BK4139","AFG","BK4117","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634396452","title":"CG Oncology price target raised to $80 from $77 at Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2634396452","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634396452?lang=en_us&edition=fundamental","pubTime":"2026-05-12 01:17","pubTimestamp":1778519879,"startTime":"0","endTime":"0","summary":"Wedbush raised the firm’s price target on CG Oncology (CGON) to $80 from $77 and keeps an Outperform rating on the shares. The firm notes the compa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cg-oncology-price-target-raised-to-80-from-77-at-wedbush-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cg-oncology-price-target-raised-to-80-from-77-at-wedbush-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGON","CG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634350202","title":"CG Oncology Analysts Boost Their Forecasts Following Q1 Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2634350202","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634350202?lang=en_us&edition=fundamental","pubTime":"2026-05-12 00:40","pubTimestamp":1778517600,"startTime":"0","endTime":"0","summary":"CG Oncology (NASDAQ:CGON) reported mixed results for Q1, with losses of 71 cents per share and sales of $1.083 million. Analysts have adjusted price targets.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/05/52458863/cg-oncology-analysts-boost-their-forecasts-following-q1-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","CG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634235203","title":"CG Oncology's BLA Completion Target for Creto in Q4 to Comfort Investors, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2634235203","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634235203?lang=en_us&edition=fundamental","pubTime":"2026-05-12 00:23","pubTimestamp":1778516580,"startTime":"0","endTime":"0","summary":"CG Oncology's (CGON) target to complete a biologics license application for cretostimogene monotherapy, or creto, in Q4 will provide investors with comfort, RBC Capital Markets said in a Friday note.C","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4211","IE00B64PRP62.GBP","CG","BK4139","ISBC","BK4135","CGON","IE00B3QW5Z07.USD","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634829182","title":"CG Oncology Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2634829182","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634829182?lang=en_us&edition=fundamental","pubTime":"2026-05-11 21:31","pubTimestamp":1778506298,"startTime":"0","endTime":"0","summary":"CG Oncology Inc reports results for the quarter ended March 31 - Earnings SummaryCG Oncology Inc CGON.OQ reported a quarterly adjusted loss of 71 cents per share for the quarter ended March 31, lower ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nL8N41O1FV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634281891","title":"CG Oncology Is Maintained at Outperform by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2634281891","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634281891?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:37","pubTimestamp":1778503020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CGON/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 11, 2026 08:37 ET (12:37 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CG","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634994289","title":"CG Oncology, Inc. (CGON) Receives a Rating Update from a Top Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2634994289","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634994289?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:19","pubTimestamp":1778501960,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Sam Slutsky reiterated a Buy rating on CG Oncology, Inc. today and set a price target of $108.00. Slutsky covers the Health...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cg-oncology-inc-cgon-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cg-oncology-inc-cgon-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CG","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634949289","title":"RBC Capital Remains a Buy on CG Oncology, Inc. (CGON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634949289","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634949289?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:16","pubTimestamp":1778501797,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Leonid Timashev maintained a Buy rating on CG Oncology, Inc. on May 8 and set a price target of $81.00. The company’s shares cl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-buy-on-cg-oncology-inc-cgon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-buy-on-cg-oncology-inc-cgon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGON","CG","LU1267930573.SGD","LU0029864427.USD","BK4135","LU0128525929.USD","BK4207","BK4139","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU0708994859.HKD","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634286128","title":"CG Oncology Earns Buy Rating as Analyst Sees High Phase III Success Odds and Strengthened BLA Timeline for Lead Asset Creto","url":"https://stock-news.laohu8.com/highlight/detail?id=2634286128","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634286128?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:57","pubTimestamp":1778500665,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Tyler Van Buren has maintained their bullish stance on CGON stock, giving a Buy rating today. Tyler Van Buren has given his Buy ra...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/cg-oncology-earns-buy-rating-as-analyst-sees-high-phase-iii-success-odds-and-strengthened-bla-timeline-for-lead-asset-creto-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/cg-oncology-earns-buy-rating-as-analyst-sees-high-phase-iii-success-odds-and-strengthened-bla-timeline-for-lead-asset-creto-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGON","III","DBB","CG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":4,"totalSize":123,"code":"91000000","status":"200"}]}}